logo
Select company
Select metric
$ -2.52MNet Cash Flow - Operations
VS
Market
30
Sector
70
Industry
90
History
90
$ 5.37Close
$ 2.3 - $ 10.36 52-Week Range
Ticker Information

Ticker

XBIO

Company Name

XENETIC BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENETIC BIOSCIENCES INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XBIO - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -2.52M
3/31/2025$ -2.66M
12/31/2024$ -2.82M
9/30/2024$ -2.94M
6/30/2024$ -3.43M
3/31/2024$ -4.17M
12/31/2023$ -4.11M
9/30/2023$ -4.07M
6/30/2023$ -4.2M
3/31/2023$ -3.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENETIC BIOSCIENCES INC's latest trailing twelve months (TTM) CF - Operations stands at $ -4.99M.
  • Over the past 5 years, XENETIC BIOSCIENCES INC's average CF - Operations has been $ -4.12M.
  • The median CF - Operations for XENETIC BIOSCIENCES INC during this period was $ -4.21M
  • XENETIC BIOSCIENCES INC reached its highest CF - Operations over the past 5 years at $ -2.52M.
  • The lowest CF - Operations recorded by XENETIC BIOSCIENCES INC in the same timeframe $ -5.35M

XENETIC BIOSCIENCES INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
ONCO : ONCONETIX INC $ -5.47MSPRB : SPRUCE BIOSCIENCES INC $ -51.45MNAOV : NANOVIBRONIX INC $ -6.11MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -6.37MVIVS : VIVOSIM LABS INC $ -10.42MDRMA : DERMATA THERAPEUTICS INC $ -10.96MSLRX : SALARIUS PHARMACEUTICALS INC $ -4.14MGLTO : GALECTO INC $ -13.26MTOVX : THERIVA BIOLOGICS INC $ -18.07MREVB : REVELATION BIOSCIENCES INC $ -17.72M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

XBIO - Net Cash Flow - Operations, Last 5 years

$ -5.35M

Minimum

Sep 30, 2022

$ -2.52M

Maximum

Jun 30, 2025

$ -4.12M

Average

$ -4.21M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 58.3M with a standard deviation of $ 142.13M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 508.1M
average$ 58.3M
median$ 10.91M
std$ 142.13M